ICD-10-CM/PCS MS-DRG v39.1 Definitions Manual

MDC 17 Myeloproliferative diseases and disorders, poorly differentiated neoplasms

Chemotherapy with acute leukemia as secondary diagnosis

SDX Acute Leukemia	High Dose Chemo Agent	MCC	CC	DRG
Yes		Yes	n/a	837
No	Yes	Yes	n/a	837
Yes	No	No	Yes	838
No	Yes	No	n/a	838
Yes	No	No	No	839

DRG 837 CHEMOTHERAPY WITH ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS OR WITH HIGH DOSE CHEMOTHERAPY AGENT WITH MCC

DRG 838 CHEMOTHERAPY WITH ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH CC OR HIGH DOSE CHEMOTHERAPY AGENT

DRG 839 CHEMOTHERAPY WITH ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITHOUT CC/MCC

CHEMOTHERAPY

PRINCIPAL DIAGNOSIS

Z08	Encounter for follow-up examination after completed treatment for malignant neoplasm
Z5111	Encounter for antineoplastic chemotherapy
Z5112	Encounter for antineoplastic immunotherapy

ACUTE LEUKEMIA

SECONDARY DIAGNOSIS

C9100	Acute lymphoblastic leukemia not having achieved remission
C9101	Acute lymphoblastic leukemia, in remission
C9102	Acute lymphoblastic leukemia, in relapse
C9200	Acute myeloblastic leukemia, not having achieved remission
C9201	Acute myeloblastic leukemia, in remission
C9202	Acute myeloblastic leukemia, in relapse
C9240	Acute promyelocytic leukemia, not having achieved remission
C9241	Acute promyelocytic leukemia, in remission
C9242	Acute promyelocytic leukemia, in relapse
C9250	Acute myelomonocytic leukemia, not having achieved remission
C9251	Acute myelomonocytic leukemia, in remission
C9252	Acute myelomonocytic leukemia, in relapse
C9260	Acute myeloid leukemia with 11q23-abnormality not having achieved remission
C9261	Acute myeloid leukemia with 11q23-abnormality in remission
C9262	Acute myeloid leukemia with 11q23-abnormality in relapse
C92A0	Acute myeloid leukemia with multilineage dysplasia, not having achieved remission
C92A1	Acute myeloid leukemia with multilineage dysplasia, in remission
C92A2	Acute myeloid leukemia with multilineage dysplasia, in relapse
C9300	Acute monoblastic/monocytic leukemia, not having achieved remission
C9301	Acute monoblastic/monocytic leukemia, in remission
C9302	Acute monoblastic/monocytic leukemia, in relapse
C9400	Acute erythroid leukemia, not having achieved remission
C9401	Acute erythroid leukemia, in remission
C9402	Acute erythroid leukemia, in relapse
C9500	Acute leukemia of unspecified cell type not having achieved remission
C9501	Acute leukemia of unspecified cell type, in remission
C9502	Acute leukemia of unspecified cell type, in relapse

HIGH DOSE CHEMO AGENT

3E03002*	Introduction of High-dose Interleukin-2 into Peripheral Vein, Open Approach
3E03302*	Introduction of High-dose Interleukin-2 into Peripheral Vein, Percutaneous Approach
3E04002*	Introduction of High-dose Interleukin-2 into Central Vein, Open Approach
3E04302*	Introduction of High-dose Interleukin-2 into Central Vein, Percutaneous Approach
3E05002*	Introduction of High-dose Interleukin-2 into Peripheral Artery, Open Approach
3E05302*	Introduction of High-dose Interleukin-2 into Peripheral Artery, Percutaneous Approach
3E06002*	Introduction of High-dose Interleukin-2 into Central Artery, Open Approach
3E06302*	Introduction of High-dose Interleukin-2 into Central Artery, Percutaneous Approach
3E0R302*	Introduction of High-dose Interleukin-2 into Spinal Canal, Percutaneous Approach
3E0S302*	Introduction of High-dose Interleukin-2 into Epidural Space, Percutaneous Approach

Centers for Medicare & Medicaid Services, 7500 Security Boulevard Baltimore, MD 21244
16 Mar 2022 16:20:17
CMS, code-revision=332, description-revision=1327

SDX Acute Leukemia	High Dose Chemo Agent	MCC	CC	DRG
Yes		Yes	n/a	837
No	Yes	Yes	n/a	837
Yes	No	No	Yes	838
No	Yes	No	n/a	838
Yes	No	No	No	839

SDX Acute Leukemia	High Dose Chemo Agent	MCC	CC	DRG
Yes		Yes	n/a	837
No	Yes	Yes	n/a	837
Yes	No	No	Yes	838
No	Yes	No	n/a	838
Yes	No	No	No	839

SDX Acute Leukemia	High Dose Chemo Agent	MCC	CC	DRG
Yes		Yes	n/a	837
No	Yes	Yes	n/a	837
Yes	No	No	Yes	838
No	Yes	No	n/a	838
Yes	No	No	No	839